Researchers discover toxic form of alpha-synuclein
New research demonstrates how the protein alpha-synuclein could cause the loss of cells in Parkinson’s.
Tapeworm drug shows promise for Parkinson's
Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.
Tremor linked to genetic change in fruit flies
Parkinson's UK funded researchers at the University of York have observed tremors in fruit flies with a genetic mutation linked to Parkinson's.
Fast-track route for medicines and technology announced
New fast-track route could shave years off the time it takes for people with Parkinson's to benefit from new and better treatments.
Researchers solve structure of key Parkinson's protein
Researchers at Dundee University have solved the 3D structure of PINK1, a protein that plays a protective role in brain cells.
Further evidence on the benefits of pimavanserin
UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.
Asthma drugs could decrease risk of Parkinson's
New research suggests that a type of asthma drug that activates a protein called beta-adrenoceptors, may decrease risk of Parkinson's.
Groundbreaking results for 2 cell transplantation studies
Results published today make significant strides into our understanding of cell transplants for Parkinson's.
Diabetes drug may have potential for Parkinson's
UK researchers have shared promising results of a phase 2 clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's.
Study highlights the role of the immune system in Parkinson's
New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.